Vor Biopharma Inc.
VOR
$16.10
$1.177.84%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -112.75% | 312.00% | 48.36% | -4,744.15% | -5.78% |
| Total Depreciation and Amortization | 21.74% | 1,050.00% | -99.90% | 146.91% | -4.62% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 111.26% | -331.95% | -50.78% | 47,280.73% | 8.93% |
| Change in Net Operating Assets | -591.77% | -37.51% | 9.25% | 275.47% | -193.68% |
| Cash from Operations | -67.74% | 57.51% | -52.52% | -13.26% | -29.10% |
| Capital Expenditure | 84.71% | -28.69% | -60.53% | 34.20% | -220.83% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -440.87% | -- | -- | -200.00% | -- |
| Cash from Investing | -437.50% | -19,971.31% | -137.77% | 380.87% | -219.44% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -84.47% | 2,074.95% | 22,797.94% | -- | -- |
| Repurchase of Common Stock | 98.65% | -678.95% | 40.63% | 41.82% | -83.33% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 99.93% | -27,136.55% | -100.37% | 31,860.44% | 76.30% |
| Cash from Financing | -75.68% | 1,328.37% | -87.69% | 28,988.61% | -101.14% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -196.01% | 829.44% | -123.03% | 540.50% | -209.44% |